using hep2 cells to study antinuclear antibodies has resulted in the discovery of the anti-centromere antibody which is thought to separate the crest syndrome from progressive systemic sclerosis ( scleroderma ) .
C0036421
progressive systemic sclerosis
C0011644
scleroderma